Advanced Invasive Extramammary Paget's Disease Concomitant with Cecal Cancer Possessing Rare Variant of TP53 Single Nucleotide Polymorphism

Yumi Kambayashi, Taku Fujimura, Kentaro Ohuchi, Hisayuki Tono, Yoshihiro Ishida, Atsushi Otsuka, Setsuya Aiba

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with invasive extramammary Paget's disease have an increased risk of secondary malignancy, mostly occurring colorectal carcinoma. TP53 is a regulator of apoptosis, cell cycle arrest, and DNA damage response pathways, and has been reported as one of the genetic biomarkers for colorectal carcinoma. In this report, we describe a case of advanced invasive EMPD concomitant with cecal cancer with a rare variant of TP53 single nucleotide polymorphism (rs121912665). To our knowledge, there is no English report that presents EMPD concomitant with cecal carcinoma.

Original languageEnglish
Pages (from-to)855-860
Number of pages6
JournalCase Reports in Oncology
Volume12
Issue number3
DOIs
Publication statusPublished - 2019 Sep 1

Keywords

  • CK20
  • CK7
  • Cecal carcinoma
  • EMPD
  • Immunohistochemical staining
  • TP53 SNP

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Advanced Invasive Extramammary Paget's Disease Concomitant with Cecal Cancer Possessing Rare Variant of TP53 Single Nucleotide Polymorphism'. Together they form a unique fingerprint.

Cite this